These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 27296312)

  • 1. Current Perspectives on Novel Drug Delivery Systems and Therapies for Management of Prostate Cancer: An Inclusive Review.
    Bhosale RR; Gangadharappa HV; Hani U; Ali M Osmani R; Vaghela R; Kulkarni PK; Koganti VS
    Curr Drug Targets; 2017; 18(11):1233-1249. PubMed ID: 27296312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Perspectives on Novel Drug Carrier Systems and Therapies for Management of Pancreatic Cancer: An Updated Inclusive Review.
    Bhosale RR; Gangadharappa HV; Gowda DV; Osmani RAMA; Vaghela R; Kulkarni PK; Sairam KV; Gurupadayya B
    Crit Rev Ther Drug Carrier Syst; 2018; 35(3):195-292. PubMed ID: 29953347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current Perspectives on Therapies, Including Drug Delivery Systems, for Managing Glioblastoma Multiforme.
    Bhaskaran M; Devegowda VG; Gupta VK; Shivachar A; Bhosale RR; Arunachalam M; Vaishnavi T
    ACS Chem Neurosci; 2020 Oct; 11(19):2962-2977. PubMed ID: 32945654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current Perspectives on Novel Drug Delivery Systems and Approaches for Management of Cervical Cancer: A Comprehensive Review.
    Hani U; Osmani RA; Bhosale RR; Shivakumar HG; Kulkarni PK
    Curr Drug Targets; 2016; 17(3):337-52. PubMed ID: 25944014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoparticle therapeutics for prostate cancer treatment.
    Sanna V; Sechi M
    Nanomedicine; 2012 Sep; 8 Suppl 1():S31-6. PubMed ID: 22640911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface-active liposomes for targeted cancer therapy.
    Sofou S
    Nanomedicine (Lond); 2007 Oct; 2(5):711-24. PubMed ID: 17976032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RGD peptide conjugated liposomal drug delivery system for enhance therapeutic efficacy in treating bone metastasis from prostate cancer.
    Wang F; Chen L; Zhang R; Chen Z; Zhu L
    J Control Release; 2014 Dec; 196():222-33. PubMed ID: 25456829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted therapy for advanced prostate cancer: Looking through new lenses.
    Vogiatzi P; Cassone M; Claudio L; Claudio PP
    Drug News Perspect; 2009 Dec; 22(10):593-601. PubMed ID: 20140279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanocarriers for cancer-targeted drug delivery.
    Kumari P; Ghosh B; Biswas S
    J Drug Target; 2016; 24(3):179-91. PubMed ID: 26061298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current prospects and challenges of nanomedicine delivery in prostate cancer therapy.
    Gupta S; Gupta PK; Dharanivasan G; Verma RS
    Nanomedicine (Lond); 2017 Dec; 12(23):2675-2692. PubMed ID: 29098929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted nanomedicine modalities for prostate cancer treatment.
    Cohen L; Livney YD; Assaraf YG
    Drug Resist Updat; 2021 May; 56():100762. PubMed ID: 33857756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent Advances in Nanosystems and Strategies for Managing Leishmaniasis.
    Vaghela R; Kulkarni PK; Osmani RAM; Bhosale RR; Naga Sravan Kumar Varma V
    Curr Drug Targets; 2017; 18(14):1598-1621. PubMed ID: 27033193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic efficacy of nanomedicines for prostate cancer: An update.
    Lakshmanan VK
    Investig Clin Urol; 2016 Jan; 57(1):21-9. PubMed ID: 26966723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Strategies for Targeting Prostate Cancer.
    Panda PK; Saraf S; Tiwari A; Verma A; Raikwar S; Jain A; Jain SK
    Curr Drug Deliv; 2019; 16(8):712-727. PubMed ID: 31433757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposomal nanomedicines in the treatment of prostate cancer.
    Kroon J; Metselaar JM; Storm G; van der Pluijm G
    Cancer Treat Rev; 2014 May; 40(4):578-84. PubMed ID: 24216226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Advances in Nanoparticle-Based Targeted Drug-Delivery Systems Against Cancer and Role of Tumor Microenvironment.
    Ashfaq UA; Riaz M; Yasmeen E; Yousaf MZ
    Crit Rev Ther Drug Carrier Syst; 2017; 34(4):317-353. PubMed ID: 29199588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug Delivery in Cancer Therapy, Quo Vadis?
    Lu ZR; Qiao P
    Mol Pharm; 2018 Sep; 15(9):3603-3616. PubMed ID: 29553749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active-targeted nanotherapy strategies for prostate cancer.
    Katsogiannou M; Peng L; Catapano CV; Rocchi P
    Curr Cancer Drug Targets; 2011 Oct; 11(8):954-65. PubMed ID: 21861840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent progress in drug delivery systems for anticancer agents.
    Kim CK; Lim SJ
    Arch Pharm Res; 2002 Jun; 25(3):229-39. PubMed ID: 12135091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.